Viewing Study NCT00564928

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:37 AM
Ignite Modification Date: 2026-03-12 @ 1:33 PM
Study NCT ID: NCT00564928
Status: COMPLETED
Last Update Posted: 2012-12-11
First Post: 2007-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer
Sponsor: Infinity Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
None Prostatic Neoplasms View
None Cancer of the Prostate View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hormone resistant prostate cancer View
None castrate resistant prostate cancer View
None HRPC View
None CRPC View